P2.03-044 OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC
2018 ◽
Vol 36
(15_suppl)
◽
pp. e24221-e24221
Keyword(s):
2014 ◽
Vol 32
(15_suppl)
◽
pp. 11049-11049
2020 ◽
Vol 15
(6)
◽
pp. 1015-1026
◽
2017 ◽
Vol 12
(1)
◽
pp. S1205-S1206
◽